In a survey of pediatric patients with vitiligo, only 51.4% were offered narrowband ultraviolet B (NB-UVB) phototherapy, and 45.1% received this treatment before the age of 18 years. The main barriers ...

New Orleans, LA – A randomized, placebo-controlled pilot study led by Frank Lau, MD, FACS, Associate Professor of Clinical Surgery at LSU Health New Orleans School of Medicine, has found that ...

GLASGOW, Scotland — There are wide variations across Europe in how the different forms of phototherapy are used in the treatment of atopic eczema for both adults and children, reveals a region-wide ...

Oral psoralen – UV-A therapy was found to be more effective than narrowband UV-B therapy in treating patients with chronic plaque psoriasis, according to an article in the July issue of Archives of ...

Credit: Getty Images The Vitiligo Task Force developed expert-based recommendations for the treatment of vitiligo, worldwide. The International Vitiligo Task Force has issued up-to-date evidence-based ...

Think about a world where a light is restoring your skin’s lost color. Red light therapy lamp is becoming popular for skin pigmentation treatment among people with vitiligo. The common skin condition, ...

HORSHAM, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...

Zerigo Health’s latest software release includes integrated, guideline-recommended phototherapy dosing protocols for the treatment of atopic dermatitis (commonly referred to as eczema), in addition to ...

SCENESSE® is being evaluated as a systemic repigmentation therapy for vitiligo patients, with a clinical focus on adolescent (12 years and above) and adult patients with darker skin types (Fitzpatrick ...

Patients with vitiligo can increase repigmentation through vitamin D and topical corticosteroid therapy. Combining topical corticosteroids with vitamin D analogues resulted in greater efficacy rates ...

Psoriasis: When the ‘usual suspect’ therapy works Topical corticosteroids and ultraviolet therapies are still proving to be strong competitors in psoriasis treatment. Ms. S, aged 37 years, presented ...